SBIR-STTR Award

Photoprotection of Skin by Topical Selenium
Award last edited on: 7/17/03

Sponsored Program
SBIR
Awarding Agency
NIH : NCI
Total Award Amount
$75,000
Award Phase
1
Solicitation Topic Code
-----

Principal Investigator
Mostafa M Omar

Company Information

Phytoceuticals Inc

37 Midland Avenue
Elmwood Park, NJ 07407
   (201) 791-2255
   mostafao@aol.com
   N/A
Location: Single
Congr. District: 09
County: Bergen

Phase I

Contract Number: 1R43CA094484-01
Start Date: 00/00/00    Completed: 00/00/00
Phase I year
2002
Phase I Amount
$75,000
Ultraviolet (UV) radiation causes oxidative damage to skin which can cause skin cancer, alter the behavior of skin cancer (typically making the cancer more aggressive), and/or cause photoaging. Topical selenium compounds may prevent this damage. In an attempt to moderate UV-induced photodamage, we will formulate topical selenium products and test them in pig skin. Formulations - including selenium sulfite, L-selenomethionine, selenotrisulfide, derivatives of lipoic acid and lipoamide - will be tested for percutaneous absorption in pig skin. Those formulations having the best characteristics will be chosen for further study. We will irradiate normal pig skin with UV radiation. We will assess histological changes and quantitate damage by measuring apoptosis, nucleic acid oxidation, and matrix metalloproteinase induction. We will determine the relative protection of topical selenium formulations to inhibit photodamage.

Thesaurus Terms:
drug screening /evaluation, oxidative stress, photoprotective agent, selenium, topical drug application, ultraviolet radiation apoptosis, selenated sulfur aminoacid, selenomethionine, short chain fatty acid, sunscreen histology, swine

Phase II

Contract Number: ----------
Start Date: 00/00/00    Completed: 00/00/00
Phase II year
----
Phase II Amount
----